跳至主要内容
临床试验/NCT07177482
NCT07177482招募中不适用

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Deling Li2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年7月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
2
主要终点
Standardized uptake value of 68Ga-MY6349 in PET imaging of craniopharyngioma

研究概览

简要总结

This study aims to investigate 68Ga-MY6349, an immune-PET tracer targeting trophoblast cell surface antigen 2 (Trop2), for the noninvasive diagnosis of craniopharyngioma in vivo.

详细描述

The trophoblast cell surface antigen 2 (Trop2), encoded by the TACSTD2 gene, is a transmembrane glycoprotein that regulates epithelial malignant transformation and proliferation. Trop2 has been reported to be overexpressed in various epithelial tumors, including craniopharyngioma. 68Ga-MY6349, an immune-PET tracer targeting Trop2, has demonstrated high specificity and sensitivity in visualizing other Trop2-high solid tumors. In this research, patients with primary or recurrent craniopharyngioma scheduled for surgery will receive the preoperative 68Ga-MY6349 PET/CT in addition to standard MRI. Tumor uptake is quantified by the maximum standardized uptake value (SUVmax). The diagnostic performance of 68Ga-MY6349 PET is subsequently compared with MRI and the SUVmax is correlated with Trop2 expression levels in postoperative pathological specimens.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
14 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • must be able to provide a written informed consent
  • radiologically presumed and/or histologically confirmed craniopharyngioma scheduled for resection
  • adequate clinical condition (Karnofsky performance status ≥70)

排除标准

  • concomitant major central nervous system disorders
  • severe hepatic or renal dysfunction
  • history of severe allergy or hypersensitivity to intravenous radiographic contrast agents
  • claustrophobia precluding PET/CT or MRI examinations
  • pregnancy or breastfeeding

结局指标

主要结局

Standardized uptake value of 68Ga-MY6349 in PET imaging of craniopharyngioma

时间窗: Within 1 week after PET imaging.

The semiquantitative analysis will be performed by the same person for all the cases, and the standardized uptake value (SUV) of the tracer in craniopharyngioma will be measured.

Standardized uptake value of 68Ga-MY6349 in PET imaging of craniopharyngioma

时间窗: Within 1 week after PET imaging.

The semiquantitative analysis will be performed by the same person for all the cases, and the standardized uptake value (SUV) of the tracer in craniopharyngioma will be measured.

次要结局

  • Evaluate the feasibility of PET/CT imaging with 68Ga-MY6349 for the non-invasive assessment of Trop2 expression in craniopharyngioma.(Within 2 week after surgery.)
  • Evaluate the feasibility of PET/CT imaging with 68Ga-MY6349 for the non-invasive assessment of Trop2 expression in craniopharyngioma.(Within 2 week after surgery.)

研究者

发起方
Deling Li
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Deling Li

Professor

Beijing Tiantan Hospital

研究点 (2)

Loading locations...

相似试验